Article Type : Research Article
Authors : Wu J and Zha P
Keywords : Randomized controlled clinical trials; Mathematical model; Binary scale; Statistical analysis; Epidemiological model; Reductionist treatments; Failure of medicine
Medicine adopted several presumptions when it evolved from
ancient experienced-based mind-body medicine to its current art. To understand
its failure in finding cures for chronic diseases, we examined the
presumptions, and found that statistical
population of health properties does not exist for most research purposes,
mathematical models are misused to model intensive properties, synthetic drugs
are inherently more dangerous than nature-made medicines under their respective
application conditions, binary disease classification introduced excessive
errors, and reductionist treatments are inferior and inherently dangerous. We
found that clinical trials are valid only for research where treatment effect
is much stronger than the total effects of all interfering or co-causal factors
or where errors introduced by misused mathematical models can be tolerated. In
all other situations, clinical trials introduce excessive errors and fail to
detect treatment effects, or produce biased, incorrect or wrong results. We further
found that chronic diseases are manifestation of small departures in multiple
processes attributes in distinctive personal metabolic pathways networks, that
medicine lacks required accuracy for accurately characterizing chronic
diseases, and that reductionist treatments are good at controlling symptoms and
safe only for short-term uses. For all stated reasons, as long as medicine
continues relying on the flawed presumptions, it can never find predictable
cures for chronic diseases. By implication, predictable cures to chronic
diseases are adjustments to lifestyle, dietary, emotional, and environmental
factors to slowly correct departures in process attributes responsible for
chronic diseases.
The
systematic failure of medicine in chronic diseases was extensively discussed as
early as 1875 [1], and often the subjects of critique by media [2-4]. As of
today, most chronic diseases have no predictable cure in medicine [5].
Population-based treatments have failed in cancer, heart diseases, mental
disease, etc. [6-8]. Chronic diseases are the biggest economic burden in the
U.S. [7] and are predicted to consume about $3.5 trillion by 2050 [8]. From
medical performance, we see two distinctively patterns: treatments for acute
diseases are successful, but treatments for chronic diseases and cancer
consistently fail. Thus, we suspect that the failure in chronic diseases must
be of systematic nature that might have precluded cures for chronic diseases.
In
our prior study, we found that controlled trials are improper methods for
studying weak health factors when many interfering factors (equivalent to
covariates in statistics) normally exist in clinical trials [9]. Our findings
support the conclusions that all controlled clinical trials are biased [10].
Our prior model study shows a common scenario where each weak treatment or
factor cannot be resolved or accurately determined if it is interfered with by
at least one to thousands of other factors that have similar degrees of
effects. If a weak factor is studied in a clinical trial, it is improperly
rejected as experimental errors. Most assumptions used in clinical trials and
statistical analysis have not been considered [9].
To
understand how weak factors affect disease outcomes, we need to examine
biological pathways and disease-controlling mechanisms. We have shown that
randomized controlled trials do not have the power to overcome sensitivity
limits [9]. This insufficient-accuracy problem cannot be seen from the outcomes
of clinical trials. When the validity of the research model is challenged, such
a challenge cannot be resolved by examining outcomes of research using the
model. Moreover, due to complexity of health problems and a massive number of
interfering factors that exist in clinical trials, it is impossible to find
problems by examining the data of clinical trials. To find research model
flaws, we are required to consider all kinds of evidence other than clinical
trial outcomes.
Presumptions used in medicine are part of
foundation of medicine and are taken as truth so that their validity has never
been questioned or examined. When medicine evolved from ancient medicines into
modern medicine, it changed natural medicines into synthetic drugs, changed demographic
populations into statistical populations, introduced mathematical models as
universal tools in medical research, and used the binary scale to model health
properties. To find the cause of the systematic failure in chronic diseases, we
will examine all presumptions and assumptions. The oldest presumption was that
“medicine can cure disease”. While this presumption existed in the early
history, “medicine” used in Yellow River Civilization is not the same as
medicine we mean today. We will consider what is wrong to use a population to
study chronic diseases and what problems mathematical models can create. In addition, we will examine each of the
assumptions used in clinical trials and statistical analysis to show additional
flaws from biological points of view.
We collect from the medical literature
published data and research findings which tend to support or refuse challenged
presumptions and assumptions. We rely on data from four sources: one of the
sources is research findings that establish the existence of interfering
factors and their degrees of effects. Due to an extremely large set of study
findings, we will cite only selected references, and treat others as common
knowledge. We must use this unique approach because no single set of data or
any particular findings can ever resolve this challenge. This is why conducting
one or more experiments is meaningless because the data of each study is like a
drop of water in a bucket. The second source of data we rely on is online
stories, reports from health care providers, personal stories, and our own
observations. When the validity of controlled clinical trials is under
challenge, we give more weight to those sources of evidence. Based on our prior
studies [9], we ignore negative findings from controlled trials directed to
weak factors.
Other data considered include biochemical
pathways, cellular or structural data, disease mechanisms, host responses to
stressors, immune responses, factor-factor interactions, organ-organ
interactions, rational explanations based on body structural compartment, rate
balance among different biological pathways, and balance between disease
process and healing process. Due to the large scope of issues, we do not cite
all contributors directly. The third source of data is data from simple
mathematical models to refute or support medical concepts and disease
mechanisms. Such a method is used only to show that clinical trials with
currently accepted data analysis can produce inaccurate, biased, or wrong
results, but not used to establish that the use of mathematical method is in
fact right. As we show, mathematical models are often misused if research
purpose is to assess treatment benefits and find cures. If use of mathematical
models in clinical trials is refuted as improper, clinical trials, as a
research method, fall for this reason without regarding the details of
mathematical models. The fourth source of data is the performance data in
treating diseases. However, since most performance studies are based by various
degrees, we must read them to offset potential inaccuracies. In general, the
treatment benefits of weak factors are underestimated based on our prior study
[9] and obvious logic.
FLAWS IN CLINICAL TRIALS AND POPULATION
MEDICINE
To show why clinical trials are invalid
for most research purposes, we studied its development history provided in the
medical literature [11]. To understand
mathematical models, we study biological pathways and their interactions, the
multiple interactive disease mechanisms, factor-factor interactions, and the
structural effects of tissues and organs, etc. In addition, we will show that
treatment unit additivity assumption and an implied random error assumption
fail to hold in nearly all clinical trials for studying chronic diseases.
A. Clinical Trial Development History
The development history of clinical trials
reveals that clinical trials were developed by adding components piece by piece
by different contributors in several centuries [11]. When the clinical trial
was first used, there was no need to establish a statistical population because
statistical analysis was not part of data analysis for the clinical trial.
Population used in the early human history just means a collection of members
in a demographic sense, and early medical researchers naturally liked to use a
population to study diseases because it always created an impression that a
treatment capable of curing more persons must be better than one that does not.
This is still a reason for convincing researchers today. In the early days,
there was never a need to examine the population of abstract concepts such as
biological properties, health condition, and disease outcomes. The controlled
trial on scurvy conducted by James Lind in 1747 contained most elements. By 1946, all components of randomized controlled trials have
been added. It is fair to infer that the clinical trials have gained general
acceptance before the 60’s [11] without using statistical analysis. Before
about 1980s, medical researchers did not know the massive biological properties
concerning diseases initiation, development and reversal, the complex human
immune system, and the role of the Central Nervous System. They did not have a
vantage to see how personal genomes, environmental factors, emotional states,
etc. affect health and disease properties. It was natural to presume that any
health property in different people is similar so that the values of any
property for different people can be treated as a statistical population.
Decades after clinical trials gained
general acceptance, researchers started looking into the human genome,
biochemical pathways, environmental factors, lifestyle factors, emotional
problems, etc. The effects of a large number of primitive factors on diseases
have been established by tens of thousands of studies mainly after 1980 [See
some references in Section E]. Even though, a good portion of studies is
conducted by using the population approach, affirmative findings in those
studies suffer inaccuracy by various degrees. Nevertheless, those positive
findings have firmly established that differences in health and disease
properties cannot be treated as random errors, and there is no statistical
population as far as health and disease properties are concerned.
Unfortunately, the new discoveries have not prompted medical researchers to
revisit the presumed statistical populations that had been used in the last a
few decades. We have shown that effects of massive interfering factors are
responsible for trial outcome uncertainty. When the nature of interfering
factors was not understood, it was natural to attribute trial outcome
uncertainty and conflicting findings to experimental errors. It is natural to
try to solve this problem by using misapplied statistical analysis.
Misuse of statistical analysis in clinical
trials is clearly reflected in the development history of statistics.
Statistical analysis was added to clinical trials as one of the latest added
components. The origins of statistical theory lie in the 18th-century, but
improved experimental design, hypothesis testing methods, etc. were developed
in the 1910s and 20s by William Sealy Gosset, and Ronald Fisher, and further
refinements were made in the
1930s [12]. Hypothesis tests are used to determine whether positive outcomes in
clinical trials are really caused by the treatment effect or due to
uncontrollable experimental error. Use of hypothesis tests in clinical trials
started centuries after the initial use of clinical trials and more than a
decade after the formation of modern clinical trials. Statistical analysis was added
as an additional analysis step to clinical trials from the 30s to about 60s.
When statistical analysis was added, the traditional concept population
was silently changed into a statistical population. In statistics, a
population is a set of similar items or events which is of interest for
some question or experiment. No published study has seriously discussed whether
health properties of human beings can be treated as a statistical population,
whether health properties follow any known statistical distributions, how
differences in observed health properties between different persons are more than what could cause chronic diseases, and
whether the observational values in a population can be added and divided like
fungible properties such as weight and volume.
B. Flaws in Early Statistical Studies
Past studies including those done by
Altman, Senn, Zhao and Berger [13-18] have made a presumption that any health
properties such as survival times, process attributes such as conversion rate
and intermediate concentrations, etc. in human bodies can be treated as a
statistical population [13-18]. They did so without exploring the effects of
all interfering and co-causal factors normally exist in clinical trials. An
implied presumption had been accepted for several centuries ago even though no
statistic analysis were used. It had been beyond challenges. By using this
presumption, even extremely complex health and disease properties such as
survival time and emotional health can be studied like statistical populations,
where outcome uncertainty can be attributed to random processes like rolling a
dice or blowing colored balls our of a lottery machine. After examining disease
mechanisms and existing risk-disease data, we found that no disease happens
like flipping a coin and blowing colored balls.
Due to historical reasons, early
researchers could not pay attention to biological properties and life factors
and their effects on health properties. Flaws in early studies can be
summarized as follows: first they made a presumption that disease and health
properties can be studied like drawing events and that health properties of
human beings in a treatment group can be treated as a statistical population.
They then made an assumption that disease or health properties can be mathematically
added up and divided to yield a mean for the presumed population. In doing so,
they actually made another assumption that health properties are fungible and
exchangeable, and all uncontrollable interfering factors do not exist or can be
neglected as random errors within a treatment, and failed to examine whether
treatments have different effects on different persons, how interfering factors
affect health properties, and how their plus and minus effects distort analysis
outcomes.
In the early years, they did not have the
vantage to see the irrefutable evidence that most so-called errors are not
truly random errors that are seen in statistical trials, but a combination
effect of hundreds to thousands of interfering or co-casual factors. They did
not see abundant evidence that treatments often have different levels of
effects and different-sign effects on different persons, that magnitude of
measured errors from interfering factors can be larger than treatment effects;
the interaction between a treatment and any of potential interference factors
is distinctive in each person; that interfering factors can distort treatment
effects by their positive and negative effects, with sufficient magnitudes to
distort trial outcomes, and that personal biological properties are
distinctive. Without considering external evidence, they were not in a position
to compare the effects of a treatment with the effects of interfering factors,
and naturally attributed all differences among different persons to experimental
errors.
Studies by Altman, Senn, Zha and Burger
[13-18] share several common errors: They treated health and disease properties
of human beings as populations. They assumed that the differences between
different persons happen like those in statistical sampling, but never
discussed external evidence about health properties such as process attributes
[19]. By failing to look into the nature
of all interfering factors, they bundled all contributions into experimental
errors. They concluded that baseline balance is not a concern. They never
proved that health properties of people can be treated as a statistical
population. They failed to note that differences between any two persons in a
health property is more than enough to cause a chronic disease or alter disease
outcome. If statistical analysis can fix the overwhelming problems, we could
reach an absurd conclusion that controlled trials have the power to resolve
contributory effects of any weak factors; valid scientific research does not
depend on separation method and detection technologies; and research
sensitivity limits can be overcome by running bigger clinical trials followed
by doing statistical analysis. Each of those conclusions must fail.
What is wrong is that “statistical
population” has been taken as granted for any research purpose. This is plainly
reflected nearly all medical studies that never even attempt to determine
whether a statistical population of a health property exists for intended
research purpose. When a clinical trial is used to study a chronic disease, it
is required that all persons must be similar in their chances of getting or
resisting the same disease. What is important is not physical entity such as
size or height, but the health properties to be investigated. Due to the massive
interfering factors in clinical trials, clinical trials tend to produce
different outcomes. Early researchers could not understand the sources of
uncertainty, and naturally assumed that trial uncertainty was caused by
experimental errors beyond human control. Naturally, statistical analysis was
used to solve this problem. When statistical analysis was added, population
was silently changed into statistical population. Medical researchers
have made a presumption that a statistical population exists for any health
property and any research purpose. This is evidenced by the widespread abuse of
statistical analysis in medical research publications.
While hypothesis tests are not wrong for
all research purposes, they can address only experimental uncertainties that
are truly caused by uncontrollable random errors that happen like flipping a
coin, blowing colored balls out of a lottery machine, or rolling a dice. The
massive medical research findings have firmly refuted that trial outcome
uncertainty is caused by uncontrollable random processes. Rather, the different
outcomes are caused by interfering factors that can be controlled. An implied
requirement for classical statistical trials is that the coin must have
identical weights on two sides to have the unbiased chance to produce each
outcome, all numbered balls in a lottery chamber must have the same weight,
same shape, same size, and uniform internal density, and the dice must be a
cubic with the same area on all six faces, and has the same density at every
inner locality within the dice. If the rim or density near two surfaces of a
coin is altered, it will introduce systematic errors that cannot be treated as
random errors. A coin with an altered structural feature may produce an outcome
ratio other than 1:1. The ball sizes and densities among different balls can be
changed to result in different outcome probabilities. Those problems can be
easily seen because their normal outcome ratio are known. However, systematic
errors in clinical trials cannot be determined by looking at trial results
alone, but must be determined by other studies. The systematic biases can be
established by external evidence. Systematic biases cannot be corrected without
understanding the nature of the biases. All interfering factors in clinical
trials can have systematical impacts on trial outcomes, even though they may
produce no effects. Inability or difficulty to control interfering factors is
not the reason to ignore their existence.
A vast number of the primitive factors
such as nutrition, toxins, heavy metals, exercise, emotional issues, etc. are
not really uncontrollable. Each of those factors is weak and hidden among the
rest of other factors. It is like a situation where the effect of each factor
cannot be determined but the collective effects of all factors are responsible
for diseases. Even intermediate factors such as glucose or triglycerides levels
in the blood can be altered by adjustment to lifestyle. None of those factors
work like an uncontrollable driving force that makes a spinning coin to take
one particular outcome.
Misuse of statistical analysis could not
remove the trial outcome uncertainty. Uncertainty in trial outcomes becomes
great room for manipulation of experiments. Instead investigating the inherent
flaws, medicine has tried to address this uncertainty problem by controlling
selection biases and conflict interests as remedies. Thus, we see massive
ethical regulations established after 1946 [11]. While avoidance of selection
biases can cure uncertainty caused by identifiable factors such as age, sex,
overall health, disease stages, etc, it cannot do away with outcome uncertainty
caused by a large number of other uncontrolled interfering factors such as
unknown toxin, deviated nutrients, great emotional state, etc.
Conflict-of-interest measures can never do away with outcome uncertainty except
that it has become a scapegoat for the flaws of clinical trials. Such measures
create massive administrative burden which is rarely seen in other fields such
as bridge design, aviation, automobile, etc.
C. No Statistical Population of Health
Properties
While the population concept can be used
for various purposes, the population, as used in statistical analysis in
clinical trials for diseases, can be refuted by relying on observed health
properties and known analytic data. Boys, girls, men, women, healthy persons,
and persons with unidentified diseases, etc, are expected to have different
baseline health. A valid statistical distribution must comprise the
observations that are used to study. For example, a healthy young person may
have a baseline survival time of five thousand days while an old patient may
have a baseline survival time of fifty days. Here the statistical distribution
comprise survival times. Among the persons in a trial, besides the term
“person”, they are different in biological age, physical strength, shape and
look, size and weight, biological properties, etc. They differ in physical
check-up data and laboratory analysis data [20]. Differences in local concentrations
of intermediate compounds of some biological pathways in tissue cells between
different persons could be more striking even though few studies were done to
understand such differences at the cellular level. Even if assuming that
diseases were realized in a manner like blowing human physical entities out of
a lottery machine, some persons might be “drawn” at much higher probabilities.
No population would meet statistical distribution except by approximation in
studies concerning non-health issue such as body weight and head count. In most
clinical trials, the baseline health property for each person cannot be
accurately measured and determined due to all interfering factors. The
inability to measure is not a valid basis for treating differences in health
properties as random errors.
As a general rule, when a treatment in a
clinical trial is sufficiently strong while experimental errors are relatively
small, two experiments with two measurements in each would be enough without
using statistical analysis. Statistical analysis is never required in most
experiments in analytic chemistry. In a drug trial with the endpoint being
survival time, real experimental errors are small because survival time,
treatment dates, and drug doses can be determined and recorded accurately. If
there were no interfering or co-causal factors, repeating the clinical trials
to study the drug effect in the same condition would produce consistent results
without using statistical analysis. However, interfering factors cannot be
characterized in reality. In a trial involving a poorly defined treatment such
as a stress-relieving method, part of outcome uncertainty is caused by the
uncertainty in treatment definition; and part of the outcome uncertainty is
caused by other interfering factors. Statistics is not a suitable method for
taking care of interfering factors and definition uncertainty of treatments.
D. Problems in Health Properties
We will discuss several model problems
that make population presumption fail.
(1) Canceled effects of a treatment: A first problem is that a factor or
treatment can have positive effects or negative effects on different persons.
For example, to improve vitamin D supply, its levels in blood of a sample of
a population can be represented by a mean and a standard deviation. This mean
may be used to determine the total amount of vitamin D supplement required for
correcting vitamin D deficiency for the population. Since vitamin levels
actually vary among persons, the amounts of supplement intakes cannot be
determined on the basis of the population’s mean but on the actual vitamin
level in each person. If the same amount of vitamin supplement is
indiscriminately used by all persons, the amount is insufficient to those with
low vitamin levels but may intoxicate those with high vitamin levels. This
treatment will have both positive effects on some persons and negative effects
on others. If we assume that 50% persons need to increase vitamin D while the
other 50% of persons do not, vitamin D supplement may happen to show a net
zero. This is wrong because it would benefit 50% of the treatment group if vitamin D supplement
is not used in those with excessive vitamin D levels. This problem cannot be
corrected by using a control. The
supplement treatment has zero over its baseline, and the control group also has
a baseline. So, the clinical trial shows no benefit. In reality, the effect of
vitamin D is more complex than this. Even some persons in the control might have excessive vitamin
D. If they reduce their vitamin D intake from their diet, the baseline for the
control increases and thus result in a a negative result for the treatment.
However, if vitamin D is administrated among those who need it, the supplement
may benefit 30% the treatment group, and the restrictive measure may “benefit”
25% of the control group. Then, the net responsive rate would be 30% of the
treatment group and 25% of the control group, rather than 0%. This implies that
clinical trial is terribly wrong.
An
overwhelming number of factors can have both positive effects, no effect and
negative effects on different persons for any health problem. Each of all
nutrients, physical exercises, measures to reduce toxic pollutants, etc. is
expected to have positive effects, no effect, and negative effects. The
averaging operation used in clinical trials always produce meaningless results.
“Lack of effect” is false because it is an improper average; a negative mean is
wrong because at least some persons need the vitamin; and a positive mean may
be underestimated because the values have been brought down by those who have
toxicity levels. Thus findings based on clinical trials are meaningless and
cannot be used as treatment guidelines.
(2) Distortions by an interfering factor: Even if the treatment or the treatment factor has a fixed positive effect on a health property on all subjects, this constant number cannot be accurately determined. This constant-effect assumption must be false, but we use it to show that a large number of interfering factors can distort the treatment effect. All interfering factors have positive or negative effects on different persons. Assuming that treatment T has a fixed treatment effect on all persons, the positive and negative effect of an interfering fact can distort its effect so that it may produce a false result. This problem is caused by the inability to resolve the contribution of the treatment and the contribution of the interfering factor on each specific person. This can be shown in the following table:
Table 1: An interfering factor affects the treatment effects of a treatment of similar strength.
|
Person ID |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
Mean |
1 |
Net
Treatment Effect |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
2 |
Interfere
Factor Effect (eq. control) |
+1 |
-1 |
+1 |
-1 |
+1 |
-1 |
+1 |
-1 |
+1 |
-1 |
0 |
3 |
Observed
“Treatment” Effect |
2 |
0 |
2 |
0 |
2 |
0 |
2 |
0 |
2 |
0 |
1 |
In Table 1, the treatment has a fixed effect of 1 on all persons. One interfering factor in row 2 has positive or negative effects, and raises the variances of the observed data in row 3. The net interfering factor in row 2 could be viewed as a control. If no interfering factor exits, all values in row 2 would be near zero, all measured values would be 1, and the mean could be determined without any uncertainty. The interfering factor dramatically raises the variances of the treatment in row 3, and thus raises the threshold of rejecting the null hypothesis. The trial most probably fails to find the true benefit of the treatment. When hundreds of interfering factors exist, the variances seen for the treatment must be larger even if the interfering factors follow complex or unknown distributions.
Table 2: A strong interfering factor distorts the true effect of a weak treatment.
No |
Person ID |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
Mean |
1 |
Treatment
Effect |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
2 |
Interference
Effect (Eq. Ctl) |
+10 |
-10 |
+10 |
-10 |
+10 |
-10 |
+10 |
-10 |
+10 |
-10 |
0 |
3 |
Observed
Treatment Effect |
11 |
-9 |
11 |
-9 |
11 |
-9 |
11 |
-9 |
11 |
-9 |
1 |
In Table 2, a single strong interfering factor dramatically increases the variances of the observed data. The massive variations of the interfering factor find its way into the values of the treatment group relative to a control. Due to the massive variances between different persons within the treatment group, the true treatment effect in row 1 may be completely hidden in the interfering effect. Although the treatment mean is detected as unbiased, the enlarged variances will result in a much higher threshold for rejecting the null hypothesis. Based on other observational data, we must say that the variances from different persons are very high and result in failure to reject the null hypothesis. We suspect that strong interfering factors are very common in studies intended to study weak and slow-delivery environmental and lifestyle factors. In such situations, clinical trials always produce false negative findings.
Table 3: A strong interfering factor overrides a weak treatment.
|
Person ID |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
“Mean” |
1 |
Net
Treatment Effect |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
2 |
Interference
Effect (Eq. Ctl) |
+10 |
-10 |
-10 |
+10 |
-10 |
-10 |
+10 |
-10 |
-10 |
-10 |
-4.0 |
3 |
Observed
Treatment Effect |
11 |
-9 |
-9 |
11 |
-9 |
-9 |
11 |
-9 |
-9 |
-9 |
-3 |
In Table 3, a single strong interfering
factor has a biased effect on the measured health property of both treatment
and control groups. This kind of interfering factors include fears, development
stage, aging, seasonable effects, exposure to bad news, etc. that strike all
subjects in both the treatment and control groups. It can dramatically increase
the variances of the observed data. In addition, it also moves the measured
values as well as the mean to the negative side. Even though the treatment has
a net effect of 1 on each person, the observed values are still negative. In
addition, aging, development stage, seasonal factor, or exposure to bad news
may interact with the treatment. A treatment may have curative benefits, but
negative news may make all subjects so sad that the news might have suppressed
the immune system or the whole body health. Due to the large variances and
negative interactions, the true treatment effect is most probably rejected as
errors.
In clinical trials, there are hundreds to
thousands of interfering factors. Their variances can be added like the
variances of random variables following well known distributions and their
means can be added up [9]. For unknown distributions, the final variances
depend on the number of interfering factors and their effects on variances of
the treatment group. In clinical trials, they are automatically treated as the
variances of errors. This raises the test statistic for rejecting the null
hypothesis and thus results in acceptance of the null hypothesis or failure to
recognize weak treatment effects.
(3) Distortions by interactions: The impact of interfering factors in
clinical trials cannot be corrected by achieving baseline balance between the
treatment group and the control group. This can be shown by the interactions
between the treatment and interfering factors. Assuming that treatment T is
under the influences of uncontrollable interfering factors (H1, H2...,
Hn), the detectable treatment value for a person is ATi=?(Ti+Ti-Hj=1+Ti-Hj=2+…,Ti-Hj=n).
Each interfering factor Hj causes plus and minus affects (T-Hj)
over an imagined treatment Ti. Some interfering factors may raise
the treatment effect by various degrees while other interfering factors may
depress the treatment effect by various degrees. The net effect of the
treatment on a person depends on the treatment and all interaction effects.
Thus, the net treatment effect on a particular person must be different from
the net treatment effect on another person. In the control, the correspondent
treatment term does not exist (it is zero). We ignore each of the interfering
factors. All interaction terms (Ti-Hj=1+Ti-Hj=2+…,Ti-Hj=n)
would depend on the treatment. It is possible that a treatment is predicted to
have beneficial effects on a disease, but the interactions with other factors
might have brought the predicted effect down to nothing or a negative value.
This problem is very serious if many of the H1, H2..., Hn
terms are larger than Ti. Because the number and impact degree of
interfering factors are unique in each person, the effect of treatment will be
altered by different degrees in different persons. This might be the reason
many drugs do not deliver same intended benefits.
The total treatment effect for the
treatment group is the sum of all treatment effects on all persons (Ignoring
the problem in additivity for the time being). A large number of interfering
factors interact with the treatment. If the interference factors interact with
the treatment in an unpredictable way, the average of the treatment effects is
meaningless. The nature of interactions is determined by the treatment OR
interfering factors. For example, a calcium supplement is predicted to benefit
bone health, but a high daily sodium intake promotes calcium loss. The sodium’s
effect on calcium balance depends on personal sodium intakes. Similarly,
exercise can beneficially affect innate immunity, acquired immunity, etc, and
people vary in doing exercises. Exercise can dramatically raise the beneficial
role of other treatments such as nutrition and detoxification of heavy metals.
Upper and down shifts of baseline health properties cannot be determined
experimentally for specific persons. Thus, a better strategy for formulating a
treatment is use of a theoretical method to predict upper- or down-shifts of
health properties which are caused by interfering factors. In the example, a
simple mathematical model is used to characterize the treatment effect and its
interactions with interfering factors. However, accurate interactions cannot be
characterized accurately by using simply mathematical models due to multiple
layers of complex healing and disease mechanisms.
(4) Problems caused by slow speed: One unique problem in human health is
that many lifestyle factors affect health and diseases slowly. This problem is
an additional reason for the failure of clinical trials. Even if a treatment is
relatively strong, it cannot be detected in a short clinical trial. The
treatment may be unable to trump the effects of random and unpredictable
interfering factors. Exercise is a very weak factor if it is examined in a
short-term trial. No benefit can be detected in a short time trial. Their
benefits are seen in long-term studies. If exercise is examined in a long-term
trial, its true benefit is interfered with by certain factors that also have
systematic impacts. Interfering factors include ages, aging, development stage,
menopause stage, hospital isolation, etc. For people at advanced ages, part of
the long-term treatment effects is more easily distorted by interference factors.
A NEW LIFE MODEL AND INTERFERING FACTORS
We will present evidence
on some well-known interference or co-causal factors that can affect human
health and disease outcome. In the life model, interference factors mean any
factor that could affect human health and disease outcome. They include things
like working habit, thinking habit, the way of breathing, air freshness, the
order of doing things and things, and a large number of things that might have
been found to have no bearing on diseases in clinical trials. Due to the
extremely large scope of interference factors, we can present only a small
number of them.
A. Evidence Showing Interfering Factors
Each person is a unique being by personal
genome [22]. The typical difference between the genomes of two individuals was
estimated to be 20 million base pairs (or 0.6% of the total of 3.2 billion base
pairs) [22]. Moreover, even identical twins
can become different beings by epigenetic changes that have an effect of
turning on or off gene expressions [23-24]. Each disease like cancer is a
distinctive product of personal genome, diet, living environment, etc. [25-26].
Since genetics cannot be altered, we focus on diets, personal activities,
lifestyle, environment, emotional state, etc. There is no need to distinguish
between associated factors and causal factors, which are used in medicine.
All factors that a person may be exposed
to can affect the person’s health. Emotional shock, chronic stress and social
isolation, etc. can affect inflammation degree [26-28], the immune system
[29-32], influenza and respiratory infection [34-36], cancer development and
metastasis [37-40], heart diseases [41-42] and drug metabolism [43]. Since the
brain controls hormonal actions and biological processes, distortions in the
brain must affect correspondent tissue ecosystems. The critical role of the CNS
was described in 1875 [1]. Nutrition affects immunity to viral infection
[44-46], other infection [47-49]?, viral pathogenicity [50], etc. Selenium
affects viral mutations [51]; and Zink affects the risk of pneumonia in the elderly [54]. Obesity affects immunity to
infection, inflammation, and immune responses [55-62]. Excessive cell phone
usage increases the risks of brain tumors [62-65].
Metals, including lead, cadmium, mercury, arsenic, chromium,
copper, selenium, nickel, silver, and zinc, and other metallic contaminants
including aluminum, cesium, cobalt, manganese, molybdenum, strontium, and
uranium are found in living organisms, plants, contaminated vegetables,
industrial materials and polymers, soil and land resources, polluted air, and
polluted water [66]. Most heavy metals such as aluminum, arsenic, beryllium,
cadmium, lead, mercury, nickel, and radium increase risks of cancers in lungs,
kidneys, liver, stomach, intestines, bladder, colon, stomach, nasopharynx, pancreas, breast,
gallbladder, esophagus, prostate, testes, gastrointestinal track, skins, and
lymphs [67-69]. Exposure to arsenic, lead, cadmium, and copper is associated
with increased risks getting cardiovascular diseases and coronary heart disease
[70, 71]. Heavy metals can damage cells [74], disturb the Redox balance [72,
74], and suppress the immune system often at very low concentrations [73, 74].
Many heavy metals can damage liver, kidneys, and brain and nerves [74].
Alteration of homeostasis of metals could cause the overproduction of reactive
oxygen species, induce DNA damage, lipid peroxidation, and alteration of
proteins, and thus increase the risks of developing brain tumors [75]. Heavy
metals such as lead, mercury, cadmium, and arsenic may be important
contributors to neurodevelopmental disorders and disabilities [76]. The
findings in those studies firmly establish that heavy metals can cause specific
diseases or cancer, but also cause general adverse health effects because they
can interfere with enzymatic reactions that control reaction rates of nearly
all biological pathways.
Inorganic and organic substances can have adverse health effects.
Sodium, the most common flavor is the number-one silent worldwide killer due to
its role in raising blood pressure [77]. Habitual dietary salt intake is
positively associated with the risk of gastric cancer [78]. Besides
cardiovascular diseases, a high salt intake increases risks of gastric and some
other cancers, obesity, Meniere's disease, worsening of renal disease,
triggering an asthma attack, osteoporosis, exacerbation of fluid retention,
renal calculi, etc. [79]. High sodium
intake is associated with obesity [80]. Moderately high salt intakes affect
calcium metabolism and bone health [81]. Reduction of sodium intake can reduce
both systolic and diastolic pressures [82]. Exposure to common quaternary
ammonium disinfectants may decrease fertility based on animal models [83-85].
Hydrogen peroxide may cause poisoning [86]. Lack of exercise and physical inactivity
are found to be the substantial causes of chronic diseases [87-88]. From the
benefits of exercises on cancer survival [89-100], it can be inferred that reduced exercise and
increased inactivity have adverse impacts on survival among cancer patients.
People have different organ reserve capacities [101-103], which are presumed to
be the most important factor that affects patients’ ability to survive
diseases.
Available spaces in the thoracic cages
affect personal ability to accommodate tissue swelling in the lungs [104].
Obesity is found to be a high risk factor for COVID-19 disease [105, 154].
Information stored on the CNS neurons is different, and it, like a computer
program, affects emotional health and CNS regulatory functions over the body.
Lack of medical findings is not a reason to deny its role and importance. Full
details of those factors can be presented only in a searchable database. Even
environmental factors such as oxygen [148], humidity [149], and temperature
[150] affect immunity and pathological responses to infection. The health
effects of a massive number of organic compounds, industrial materials,
industrial chemicals, pesticides, herbicides, fungicides, etc. can be found
elsewhere.
Many factors exhibit non-linear complex
health effects and may interact with each other. The CNS interacts with bone,
marrow, and the micro-environment [152]. Enteric microbiota, central and enteric nervous systems interact
though the gut-brain axis [153]. Sodium also exhibits different effects under
different use conditions. High salt (4% NaCl as well as 1% NaCl enriched tap water feed mice
for 2 weeks) inhibits tumor growth by enhancing anti-tumor immunity [155]
contrary to the long-term adverse effects. Like glucose level that has both
good and bad effects, sodium’s short-term effect may be realized by influencing
blood viscosity and fluid ionic strength while its long-term effects are most
probably realized by affecting blood pressure and the vascular system. Any
factor affecting viral diseases could also depend on a large number of other
factors that affect innate immunity, host responses, acquired immunity,
micro-circulation, and structural features of target tissues. The cited
findings are irrefutable proof that none of the interfering factors can be
ignored in the mission to find cures. Most beneficial factors can be used to
prevent diseases, and most adverse factors can be corrected to mitigate
diseases.
B. Slow Delivering Effects of Weak
Interfering Factors
To understand the nature of interfering factors, it is important
to understand event timing. Some treatments such as consuming glucose to raise
blood glucose can show immediate benefits. Other treatments or factors will
affect the biological or metabolic pathways networks without immediately
causing symptoms. It may take time to distort the biological networks. The
distorted network then slowly alters the structures of the body. This is
similar to the development of chronic diseases. Altered process attributes in
the biological or metabolic network and altered body structures also interact
with the Central Nervous system by the mind-body interactions [112-113]. The
mind-body interactions may be a mechanism for stabilizing the physical body.
Most departures in biological networks in tissue cells cannot be directly
determined in clinics because reference ranges of chemical analysis data for
normal ranges are very large. Chronic diseases are often diagnosed by examining
blood compositions, changes in cellular structures and disease biomarkers. It
is difficult to determine the effects of primitive weak factors by using those
methods.
CLOSE EXAMINATION OF KEY PRESUMPTIONS
In modern medicine, another presumption is
that every health problem can be represented by a mathematical model such as a
statistical model. It has become presumption. We refute this presumption as
being flawed by examining the assumptions used in statistical model.
A. Nonlinear Effects of A Treatment
Nearly all statistic models common used in
medicine is based on linear model. Whenever statistical analysis is used, it is
presumed that health property can be model by using linear models. If linearity
does not hold, all statistical analyses are wrong. We will show that this presumption
fails in nearly all medical research situations. Most interfering factors
influence health properties in a complex manner. For example, nutritional
intake, physical activities, sleep duration, thinking activities, environmental
factors such as temperature, atmospheric pressure, and humidity, etc. affect
personal health often by quadratic functions (if we do not resolve precise
effects at a finer scale). A low nutrient intake has negative effects, its
beneficial effect increases with intake amount, and hits an optimal point;
after this point, further increased intake causes a reduced beneficial effect,
and results in progressively increasing toxic effects. The point of the optimal
value for any factor is not static. The shape of the effect vs. concentration
curve depends on personal genome, health condition, age, physical activities,
lifestyle, diets, and emotional states, etc. This approximate quadratic pattern
is true even for physical activities. Too little sleep can hurt due to
insufficient rest time and too much sleep time may result in excessive fat
accumulation. It is even true for things like usage levels of body parts such
as hands, feet or joints. Long inactivity hurts but excessive activities also
hurt. The model assumptions used in most statistical models do not reflect the
changing and flipping natures.
Mathematical models cannot model complex
interactions of health properties and primitive interfering factors. Health
properties such as glucose level, triglycerides levels, oxygen saturation, etc.
may work like influencing factors for other health and disease properties. They
also affect other high-level health properties such as disease risks, death
rates, survival time, etc. Due to complex interactions, we found that most
health properties must affect health or disease by multiple complex functions
of a large number of primitive variables. It cannot be expressed by a simple
linear equation. There is no best nutritional profile, no best diet, no best
copper intake, no best environment, etc. for the population because the effect
of each factor also depends on other factors and personal activities. There are
no objective criteria for determining what is the best. There is no best amount
of exercise, and nor best kind of exercises for all people in a population.
Even for a given person, there is no static best value. An imagined best value
may exist only under certain evaluation conditions, and must change with age,
health condition, activity levels, emotional health and other personal,
environmental and lifestyle factors. The notion of the best value such as the
best sleep duration for a population is flawed. Linear models used in
statistics can model only simple properties like crop weights and production
yields when research purpose concerns a fungible property (having nothing to do
with health).
The unique nature of process attributes
implies that health properties are not the types of properties for mathematical
operations. Moreover, interactions between disease initiation and multiple
layers of disease defense mechanisms also refute the validity of mathematical
operations. Disease mechanisms are further influenced by a large number of
lifestyle and environmental factors. Clinical trials can produce unpredictable
and inconsistent results due to effects of influencing factors at different
layers. A factor for diseases may be found to have no effect if a strong
defensive mechanism in most human subjects can overcome initiated diseases; and
in another trial, the same factor effecting disease initiation may be found to
be a strong controlling factor if the defensive mechanism in most subjects has
been compromised. In sum, the best health measures must be based on personal
health and condition.
The unit treatment additivity assumption
is used in regression and variance analysis. Most weak factors are used as
treatments, this assumption must fail because they have positive and negative
effects on different persons. Besides, human body always has several layers of
disease mechanisms including innate, host response, acquired immune responses,
resolution of inflammation, and recovery of damage. Whether a treatment shows
its effects would depend on the mechanism targeted by a treatment relative to
other mechanisms used by other factors. A weak mechanism must be hidden within
a strong mechanism is working. Exercise may have negative effects on some
people whose blood vessels are severely damaged, but positive effects on
others. Even if a treatment has a constant effect, interfering factors can
distort their values or they always have different values as a result of their
interactions with other influencing factors. A large number of nutrients,
physical properties, environmental factors, etc. can distort treatment effects
by interacting with the treatment, making this assumption fail. Thus, a
treatment may have positive effect, negative effects in different degree. No
statistic model is good enough for model health even for one single person.
B. Improper Mathematical Averaging of
Health Properties
The notion of equating average of a
population as the best value was formed from a false perception of comparative
benefits. By using a comparison, clinical trials always produce a false
impression that the positively determined treatment must be good for the
population. Thus, treatments developed from clinical trials have been regarded
as the best in practice for centuries. The validity of controlled trials has
been presumed for centuries with no proof. The purpose of a clinical trial is
to determine whether a treatment is better than a control often by using
statistical analysis. In conducting a statistical analysis, measurement values
from all persons in the treatment group are added up to yield a mean. There is
no scientific proof that such health properties can be added and that a
computed mean can represent all persons in the treatment population.
Statistical mean may be found only if all persons in the population actually
have such a mean, and the averaging operation can remove truly random
measurement errors.
Most health properties are process
attributes such as conversion rate, the concentrations of reactant
intermediates, or the matrix of those things. In the treatment group, a mean
determined by mathematical averaging can represent none of the members in the
treatment group. If a treatment is found to have positive effects over a
control group, what is proved is that the treatment has sufficiently positive
effects on the members of the treatment group over the control. Such a positive
value can be detected if the treatment effect is stronger than the sum of all
interfering factors in the treatment group, the treatment produces beneficial
effects on more persons than it produces adverse effects of same degrees on
others within the treatment group, or the treatment has a net beneficial effect
on the treatment group over the control for whatever reasons. It does not prove
that the treatment is effective for the treatment group, is effective for
treating the disease, or is the best for all persons with the disease.
The notion that “an average represents a
population” is generally wrong unless a statistical population can be
established by independent evidence. In politics, number-based representation
is a principle imposed by will, but not natural law. In a statistical population,
the members must share enough similarities so that the members can be used to
investigate a treatment. This requirement is entirely relative to the research
purpose. Computed average can represent a population only if a statistical
population actually exists. The existence of a statistical population cannot be
proved by mathematical operation itself, reasonable data pattern or a computed
average value. Mathematical summation may determine average weight of a sesame
seed and a fighter carrier or the average heart output of an elephant and a
bird. Such averages can represent neither the weight of the sesame or the
carrier, and nor the heart output of the elephant, and nor the bird. While the
values in those two examples are extreme, similar data values do not provide a
basis for finding a statistical population. Similar reaction rates in certain
tissue cells in tigers and turtles do not make the rates a statistical
population (even if turtle’s mean may be used to estimate the tiger’s mean in
practice). It is possible that apple tree data might nicely fit into human data
purely by accident.
Existence of a statistical population must
be established by examining individual members and the purpose of
investigation. If an identical nutrient intake has a beneficial effect on one
person but a toxic effect on another person, the average value, which has the
same value, does not represent a beneficial effect for both, and nor a toxic
effect for both. While a study on nutrition intake is invalid for finding the
best treatment, the same study could be valid for estimating demand and supply.
Similarly, apple, orange, and plum in a compartment mixture could be treated as
a reasonable statistical population if the investigation purpose is to estimate
packaging volume. In contrast, the same study cannot be used to improve their
quality. Even abstract concepts may become a statistical population if their
differences do not defeat the investigation purpose. Even in many marketing
studies involving abstract concepts, statistical analysis may be reasonably
good if those abstract concepts are used to study sales in the amounts of cash (the only question is
accuracy requirement). Similarly, a deformed coin, irregular balls, and a
non-cubic dice with varying inner densities cannot be used in drawing samples
in classical statistical trials. All problems come from the need to cure
diseases or find treatments. In a vast number of medical research articles,
research purposes and accuracy requirements have been ignored. This single error
makes many medical study findings meaningless.
The permissible use of mathematical
operations for population-based study depends mainly on the purpose of
research. Grain weights may be added and divided if research purpose is to
study grain supply and demand. In this situation, grain weight is fungible
because mathematics does not differentiate sources just like market demand.
However, if the research purpose is to increase individual seed weights by
using a new treatment, grain weight is not a fungible property. We must
consider if the treatment has the same effect on each individual seed. If the
same treatment can have different effects on different seeds with different
genetic compositions, a mathematical model that the treatment has the same
effect must fail. Lifespan is partially controlled by complex biological
pathways, and thus is not fungible: extending 20 years for a boy is not the
same as extending 20 years for an elderly person. However, survival time could
meet statistical population if research purpose is to determine total community
life spans for the purpose of getting a financial reward under a lifespan-based
reward program. If a mathematical model treats positive and negative effects of
influencing factors as experimental errors, the errors must be sufficiently
smaller than the treatment effect so that study validity can be justified by
approximation. Based on this rational, mathematical operations cannot be used
to find the best treatments for persons who have distinctive biological properties.
Mathematical averaging of process
attributes is improper also because most process attributes have no standalone
meaning. One class of properties is intensive property that reflects local physical property of a
system. Examples of intensive properties include temperature, pressure,
refractive index, density. Extensive properties such as the mass and volume are
additive. Temperature is not additive because heat absorbed at different
temperature would be different, and temperature at different systems such as
water and gas means completely different things. Process attributes and health
properties are similar to intensive properties. A Civic uses fuel at the rate of 1
gal/time (where time is a suitable time unit) and an Accord consumes fuel at 2
gal/time. Their average would be 1.5 gal/time. This number may indicate average
usage of fuel from fuel supplies. However, this number cannot be used to study
the performance of the cars because the performance of each car depends on a
large number of other variables such as driving distance and weight of carried
goods. The average, 1.5 gal/time, has no meaning if it is viewed out of
context. Imposing the average to both cars would cripple both. Fuel injection
rate can be evaluated only against criteria such as shipping weight and running
distance. We can infer that all process attributes such as fuel injection rate,
coolant flow rate, heat dissipating rate, etc. from individual cars or planes
cannot be added and averaged across individual models, and then applied to any
specific model or unit.
Direct mathematical average is proper only
for fungible properties such as crop weight, production volume, count and
frequency. For such properties, the significance of each unit of weight or
volume does not depend on other associated variables. For example, direct
averaging of weight of alcohol of 99% purity and alcohol of 30% purity without
using weighting factors is improper. The net weight of two sources of alcohol
depends on their purity which is an associated variable. For nearly all health
properties, the significance of process attributes always depends on associated
variables. For example, use of a drug for raising 50 mm Hg blood pressure is
good for correcting low blood pressure, hurt those with elevated blood pressure,
and kill those with very high blood pressure. The net benefit depends on
overwhelming factors controlling the vascular system in each person.
Mathematical operations used in classical probability trials do not have such a
problem. In probability trials, events are defined accurately. The appearance
of a numbered ball, a dice position, or a coin face is not subject to
additional variables. Each outcome has the same significance as any of other
outcomes. That is the basis for adding them up to get a sum. Observing examples
in statistical books, we found that an intensive property may be used as a
statistical population only for the same system or similar systems. For
example, daily production rates of a machine can be added up and averaged for
different days because all other variables are fixed and thus the number of
product pieces is the only variable. In this example, the associated variables
can be dropped out because they are constant. Whether production rates from
different machines can be summed and averaged depends on the purpose of
mathematical operations and accuracy requirements.
Process attributes are generally not the
kind of properties that can be summed up and divided. The specific values of
process attributes do not have standalone meanings. Each of the values is
incapable of determining system performance such as health or disease states.
Glucose level, a process attribute, affects health by interacting with other
factors or variables. When the glucose level is low, it is vital to survival. If
it increases, its benefit reaches a plateau. Further increase in the glucose
level will cause negative effects by damaging the vascular system. Thus,
raising 15 mg/liter in the low end and increasing 15 mg/liter in the high end
have different effect even for the same person (glucose is dynamic); and 10
mg/liter in diabetes patients and 10 mg/liter in hypoglycemia patients have
different significance. Averaging glucose levels for diabetes patients and
hypoglycemia patients would result in a “healthy” mean, which is clearly
contrary to reality. We can find that all process attributes share this same
problem. Other examples include blood pressure, body core temperature,
metabolic intermediate concentrations, etc.
Any process attribute as well as unit
change to an attribute such as glucose level (mg/liter), red blood cells
(no/liter), white blood cells (no/liter), enzyme activity (in any units), etc.
have no standalone meaning unless it is considered for a specific person under
a set of specific conditions. Thus, a computed mean of any health property has
no meaning to each of the persons. If the reaction rate of a specific
biological pathway in one person is X while that for another person is 2X, the
mathematical average can represent neither. Intermediate concentrations also
have no meaning. A low glucose concentration would imply low conversion speed
only if the rate constant for the biological process is same. It is possible that 110 mg/liter in an obese person may
reflect even an lower conversion speed than 70 mg/liter in a young person.
Similarly, the rate constant or activity level of an enzyme has no meaning
unless it is considered in context. The high level of glucose in an obese
person might be caused by excessively slow conversion rate so that more of absorbed
glucose is backed up in the blood. Given the complexity, there is no basis to
add glucose levels for persons in a population and then say the mean is the
best. It is best for none, not even any of those in the population except by
accident.
Each process attribute in the biological
network [106-108] of a person is distinctive and this nature bars
approximations. Given the long development time of chronic disease, departure
in any process attribute in the biological network is very small [Sup. A]. Based
on above discussion, we find that all process attributes have non-linear,
complex effects on personal health, and that their effects on personal health
depend on many other associated factors or interactive factors. Personal health
values cannot be added up across different persons except in situations where
research purposes can tolerate such errors. Computed mean cannot be imposed
onto any specific person because the mean must be different from the
correspondent value for the person for all reasons stated above. All above
examples imply that imposing population means on any persons must be harmful to
the persons or even kill them. This can be seen from blood pressure, heart
output, metabolic intermediate concentrations, car repairing model or plane
repairing model. Treatments from the population approach not just have failed
to find cures but most probably have been hurting patients for centuries.
Many large-scale clinical trials such as
the TAILORx trial [109] reveal misuse of representation principle. It attempted
to get better “representation” from people by running a multiple national
trial. Since findings from clinical trials always had some kind of average of
personal numbers, they cannot represent a super majority of the persons other
than lucky persons whose numbers luckily fall on the average (which may happen
by the chance of winning a lottery). The average is not the optimal value of
any person in the trial subjects. Since the mean of a health property derived
from a population cannot represent different persons, a treatment on the basis
of such health property cannot be valid for any of participant persons except
the abstract person that does not exist. There is no basis to find that such a
treatment is best for other patients outside the trial. The flawed logic is
that the validity of the treatment for persons in the U.S. depends on how good
the treatment is to persons in Brazil.
C. Inaccuracies Introduced by the Binary
Scale And Disease Classifications
Another problem arises from using the
binary scale. Most of health properties are continuous properties except a few
things like gender and death. Most health properties actually exhibit 0 and 1
states, with 1 state further comprising values in non-linear continuous
profile. One example is exposure to a virus. Exposure can be classified as no
and yes. Among exposures, infection risk would depend on the number of viral
copies exposed. However, nearly all health properties or process attributes of
biological pathways are continuous. They differ in amount or degree. Blood
pressure may take any values in the observed range, but is artificially divided
into several ranges. The convention of disease or no-disease is imposed by
human wills and is foreign to nature. Conversion of such properties into the
binary states introduces excessive errors. By common sense, digitizing a sound
by two-bit digital scheme can introduce great distortions. Conversion of data
into the binary scale can introduce as much as 50% relative error. The 49.9%
will become zero while 50.1% will become one, but each of the two numbers could
get a different binary value. The binary scale has been widely used to
characterize health conditions, disease definitions, blood pressure, selection
of control groups, etc. The normal and abnormal system is widely used for
chemical analysis data, and thus introduces excessive errors relative to the
required accuracy for correcting chronic diseases. Categories are also used in
classifying side effects, cancer stages, etc in an attempt to break continuous
properties into categories by human wills. The use of the binary scale has a
severe tension with holistic balance necessary for maintaining health. The
worst problem is that the convention of research question. The binary scale
cannot provide precision required to characterize chronic diseases. In medical
studies, nearly all medical research articles ask a question and then provide a
yes-or-no answer. Most health properties such as blood pressure, glucose levels,
body weight, etc. are classified into two statuses. This convention affects
patient selection (patients v. Healthy persons), material selection, background
data, and measurement methods (e.g. chronic liver diseases and no liver
disease). Part or all experimental data may be acquired as non-binary
measurement data, then are processed quantitatively in statistical analysis.
Then, the resulted data are converted back to a binary scale in order to
support a conclusion. Those processes introduce too many and too bigger errors.
Even ignoring all other problems, a final conclusion like that vitamin D is
effective for treating COVID-19 is meaningless. Those under vitamin D
intoxication should never take vitamin D supplement. The biggest problem is the
use of symptom-based diagnosis method. Damages to a vital organ can range from
local and sporadic damages to organ cells to widespread damages to all cells
and whole organ to depress the organ’s function to nearly disability or death
level. Since human vital organs normally have massive functional redundancy
[101-103], binary disease categorization methods, which are frequently used in
clinical trials, consistently fail to detect side effects in early stages.
D. Inherent Dangers of Synthetic Drugs
“Medicine can cure diseases” is the oldest
presumption that everyone takes it for granted. The first synthetic drug,
chloral hydrate, was discovered in 1832 by Justus von Liebig in Gießen and
introduced as a sedative-hypnotic in 1869 [110]. Before the start of new drug
industry, all medicines, referred in the old medical literature, are natural
products comprising a mixture of natural compounds, and most medicines are even
formulations of natural products like herbs. After 1869, medicine definition
was changed without examining its validity into synthetic components [111].
There are several important changes to the original meaning. Old medicines work
like multiple-component diets with much milder effects while synthetic drugs
are used at higher concentrations. Second, early medicines are things that once
worked as selection pressure in evolution. For example, the compounds from
herbs, plants, and natural products might have found their way to human bodies
through the food chain. It is reasonable to infer that human body can tolerate
them in low concentrations. Fecundity phenotype will not be passed on to the
next generation if the person cannot tolerate natural compounds at low
concentrations, and die before reaching reproductive age. In comparison, most
human beings are not exposed to synthetic drugs, and thus selection will start
upon ingesting such compounds. Those two things affect drug side effects, long
term safety, and possibility to cure chronic diseases.
E. Flaws In Reductionist Treatment Model
Most medical treatments are developed
according to reductionist thinking. The reductionist idea is that human body is
like a machine, and any fault can be fixed by targeting the fault part. This
notion has been proved in some aspects such as organ transplant. However, we
also see severe limitations. For example, after a person has died for some
time, there is no way to revive the dead person like restarting a car. The
human ability to intervene brain is very limited. A reductionist treatment
always has two components: a treatment is developed from a population and
applied to the patient in treatment of a disease.
(1) Evidence Proving Limitations: The
flaws in clinical trials and failure of reductionist treatments are two
different things but share some common elements. We have proved that treatments
derived from clinical trials are deemed to be poor or inherently dangerous due
to mismatched application [9]. Reductionist treatments have been found poor or
unworkable in nutrition [114-115], lower back pain [116], neuroscience and brain research [117-118], diagnostics [119], exercise
[120], patient care [121-132], public health programs [124], and holistic
medicine [125-127, 151]. The evidence, taken as whole, has firmly established
that reductionist treatments are inferior. Those findings in combination of our
simulation study [9] prove that reductionism is a wrong approach to chronic
diseases.
(2) Implications of Automobile Repair: It is generally believed that a treatment
developed from a population must be good for persons A, B, C, etc. While this
idea formed in old history, it can be summarily rejected by using a car
repairing model. Automobiles made by Honda, Nissan, and Ford cannot be repaired
by using a common method or common specification because they are distinctively
designed. None of the average process properties such as fuel flow rate, heat
dissipation rate can be imposed on all of them. We now know that each human
body is also distinctively designed. Second, even for cars, many process
attributes cannot be altered without changing the whole car. For example, the
cooling system and exhaustion system for each model of car must be matched to
the rest of the car. Even the wheels for a given model of car cannot be
replaced by average sizes of the wheels used in all cars. The average of the
fuel consumption rates for a Civic and a Mercedes-Benz G550 cannot be imposed
on either the car. We should easily see that if auto repair and plane repair
industries have used a population approach, mechanical problems in automobiles
and planes must be incurable. All planes will crash.
A treatment derived by clinical trials
must be mismatched to patients. For example, John Doe suffers Vitamin A
deficiency but Jack Doe suffers Vitamin A poisoning. Both are sick even though
their average is perfect. If a treatment is developed from such a population,
the treatment reflects impermissible transfer of process attributes between two
different biological networks. The treatment cannot be valid for both of them.
This is not an isolated problem but a universal problem in treatments for
chronic diseases. Most, if not all, of nutrients, pollutants, activities
levels, etc. are expected to have both positive and negative effects. If a
treatment can affect one or more of such factors, the treatment must be
improper for a considerable portion of persons. Even if a treatment has a
constant treatment effect, the interfering factors can distort the treatment (see
Tables 1, 2, and 3). Mathematical models make impermissible averaging and
treatments deduced by the wrong methods cannot be good for anyone except by
accident.
Treatments derived from population trials
always make improper trade harmful to patients. In a mini trial comprising a
90-year old man, a 40-year old man, a 40-year female, and a 10-year old boy,
their health and disease properties must vary greatly. We acquire data and find
an averaged value in a health property for this population. The data does not
form a statistical population. If we impose the averaged value onto all of them
by an imagined measure, we should anticipate that the measure most probably
will kill all of them in a long run. Obviously, to develop a treatment by the
population approach, attempts have been made to balance age effects and sex
effects. Treatment of the old man is balanced by the need to offer benefits to
the young boy. A treatment for the man is balanced by the need to offer
benefits to the female. This mathematical averaging in data process violates
our observed principle that health property cannot be altered arbitrarily and
cannot be transferred from a person to person. Any treatment based on the
representation principle must be detrimental to all persons if the treatment is
used for the long term. This flaw cannot be cured by increasing the number of
participants in the trial. If a
treatment is better for some, it must be worse for others.
Even responsive rate used in medicine is a
poor concept. Two treatments with 5% curative rates are considered in
mathematics as same. However, they mean
completely different things if one treatment cures only females while another
cures only males. The population model makes an assumption that all persons are
treated in the same way, but in reality, they cannot. In reality, what is
really important is who will survive and who will die. Treatments determined by
using mathematical model are insensitive to personal differences and cannot be
used to formulate the best treatments for all persons. Two treatments
respectively with responsive rates of 50% and 40% lack comparative basis and
cannot be compared. If they work on entirely different persons, they would
benefit 90% of the population if each of the two treatments are matched to
right persons. If their joint responsive rate is 20%, they would benefit 70%
persons in the population.
(3) Constraints of the Metabolic Pathways
Networks: Each person
has a unique biological pathway network [106-108], and chronic diseases are
manifestation of a large number of departures in process attributes in the
network. All attributes in one person’s biological pathway network are
different from those in another person’s network. This distinctiveness is
implied by well known variations of chemical analysis data [128]. The
distinctiveness of physical check-up profile of a person is well known. If a
treatment is used on different persons, changes caused by the treatment in
process attributes in one person’s network must be different from changes in
other personal pathways networks. If the treatment is derived from a population
study, the treatment cannot be matched to any person because the personal
networks are different in different persons and the driving factors are even
more different. Thus, if a treatment is best for one person, it cannot be best
for another person.
It is obvious that a treatment cannot
correct all departures in the biological pathways network. One well known
example is the alteration of biochemical and cellular pathways in cancer
patients: attributes of six categories of biological properties (growth
signaling, cell apoptosis, anti-growth signaling, angiogenesis, tissue invasion
and metastasis, and cell replication limits) are changed in cancer patients
[108]. Those process attributes may like those shown by P1, P2…. Pn in Figure
2. The top diagram shows a plurality of normal process attributes. Fault
environmental, dietary, emotional, and lifestyle factors slowly drive some
process attributes to depart from healthy values. It is highly unlikely that
the disturbed biological networks can be corrected by using one single
synthetic drug. This may be the reason why drugs deliver results that are
poorer than what is predicted in theory. It is anticipated that application of
a number of influencing factors can have better chances to correct the
departures in process attributes responsible for chronic diseases.
(4) Drugs Cannot Fix CNS Problems: The role of the CNS was known even in 1875
[1]. Now, more and more evidence shows the important role of the CNS on
personal health and chronic diseases. The mathematical models used in medicine
cannot characterize interactions between the Central Nervous System and the
body running biological pathways. It is well known that the CNS and body
constantly exchange neuronal signals but little about the signals are
understood. It is expected that any changes caused by emotional interventions
will invite the CNS to respond. We reasonably assume that the CNS-body
interactions are to resist changes in the body. Mind and body interactions are
like a gearbox containing two gears. One gear cannot be freely altered without
making correspondent adjustment to the other.
(5) Drugs Disrupt Metabolic
Pathways Networks: All
process attributes in personal biological networks are caused by a large number
of interfering factors.
Figure 1: Environmental, dietary, emotional and lifestyle factors slowly drive the processes attributes of metabolic pathways in the pathways network to slowly depart from their normal values, resulting in chronic diseases.
Correction of problems in personal
biological or metabolic networks cannot be made by targeting only one or a few
steps in the network. This is shown in Figure 1. For example, the immune system
can be suppressed by emotional distress, chronic stress, toxins and heavy
metals, nutritional imbalance, poor vascular system attributed to lack of
exercise, toxic micro-organic byproducts, etc. The actual causes may comprise a
large number of primitive environmental, dietary, and lifestyle factors.
Simultaneous correction of hundreds of fault factors is more powerful than
doing one single treatment which may completely miss the target.
A treatment targeted to one attribute such
as P2 of one pathway lacks sufficient driving force. Such a treatment cannot
correct all departures in process attributes but most probably disturb other
process attributes. If a treatment is to alter the rate of one biological
pathway, it is impossible to tell how the treatment might alter other pathways.
Besides, responses in other pathways might depend on personal variations
(associated factors and interactive factors). Thus, one should find that
diseases cannot be cured by correcting one seemingly fault pathway. It is
possible some unexpected changes in other process attributes may make personal
health or disease worse. This is one reason that synthetic drugs fail to work.
Figure 1 shows how a chronic disease
develops, where the disease may be colon cancer. In this case, P1 to Pn could
mean, respectively, genetic mutations, foreign agents, microbiota, pollutants
and toxins, nutrition, heavy metals, vascular condition, organ functional
capacities, inflammation biomarkers, micro-circulation condition, innate
immunity, CNS condition, nerve health, glucose level, emotional states, etc.
Microbiota affects metabolic byproducts which may damage cells; foreign agents
such as infectious agents, fiber grasses and asbestos may affect tissue’s local
environment. P1 to Pn represent relative values of plural process attributes
(e.g., the glucose level) or anything that could directly or indirectly affect
the process attributes of metabolic
pathways in the metabolic networks. Each of the P1 to Pn factors may mean a
combination of a large number of lower level attributes. Foreign agents may be
anything that could disturb the metabolic pathways with an effect of promoting
cancer. Toxins may mean one or more of potentially thousands of known and
unknown compounds. Figure 2 represents
process attributes for any person. Due to difference in personal genome, the
process attributes for each person are distinctive. The baseline profile of one
person must be different from that of another person. During development,
the pathways profile is driven by a
large number of fault environmental, dietary, emotional and lifestyle factors.
Thus, it is expected that two colon cancer patients have completely different
process attributes and naturally require different adjustments to their
lifestyles. The cancer in one person may be caused by using a large amount of
salty, excessive hot, fried snacks while the cancer of the other might be
caused by excessive stress, distinctive microbiota, and lack of exercise. While
any two persons may share some common things by various degrees, they must be
treated differently to achieve best results. It is possible that some lifestyle
factors may be used in the opposite way.
(6) Oversimplified Mathematical Models: We will consider how mathematical model
might perform when it is used to predict disease outcome of COVID-19 disease
for a person. Infection diseases are mainly controlled by (1) exposures to the
virus, (2) viral reproduction ability, (3) innate immune responses and host
responses, (4) acquired immune response, and (5) the capacity to withstand
tissue damages [104, 137-142]. Thus, disease severity such as risk of death
could be expressed as multiple functions of a large number of influencing
factors under various conditions. If the virus exposure is well controlled, the
contribution from (2) to (5) will appear to have no role in the disease
outcome. If acquired immune response is fast and powerful in the early stage of
infection, all of the defense mechanism from (1) to (3) and (5) may appear to
have no role. From those large contributory ranges, we believe that a realistic
mathematical model must comprise multiple equations with various conditions.
Each of the equations may be a
linear equation, a polynomial equation, or other numeric equation, etc, which
has tens to thousands primitive lifestyle, personal, dietary, emotional, and
environmental factors. Disease severity also depends on aging or development
stage, information in neurons, hormonal regulation, epigenetic changes in
cells, menopause status, personal activities, etc. Many of the factors are
random variables so that some of the component equations are also random
variables. For a population, disease severity is just viewed as the sum of all
functions for all different persons. No solution could be found to such complex
functions, there is no way to combine all personal functions for the
population, and there is no way to solve a combined function for the
population.
A mathematical model developed for a
person cannot be used to predict disease severity for other persons unless they
are close to the person. The model may tell how to change dependent variables
to achieve a better outcome. We also found that current epidemiological models
[143-147] are irrelevant to the disease and human being. An articulation like
“warm temperature or sufficient oxygen in breathing air can cure the disease”
has far more science than a bad mathematical model. Epidemiological models
contain almost none of the biological factors. Manipulation of twenties to a
hundred factors, most of which are conceived out of imagination with no
reality, will not help solve the pandemic. Medicine needs to pay more attention
to human disease biology and personal health, rather than coins, dices, lotteries,
equations, forms, article structures, etc. It is a wrong strategy to jump onto
the population health while forgetting basic disease biology.
Strong treatment that is not matched to
the patient condition must produce drug side effects if the treatment is used
for a long time [129-136].
DISCUSSION
A. Overwhelming Flaws In Medicine
All presumptions -- treating health
property as a statistical population, using synthetic drugs as medicines, using
mathematical models, disease classification, and using reductionist treatments
-- are refuted as invalid unless they are used for purposes unrelated to
treatment of chronic diseases. Other kind of population studies share one of
more of those flaws. When medicine evolved from experienced-based ancient
medicine to modern medicine, it silently changed from multiple-components slow-working natural medicines into highly
concentrated synthetic drugs, changed the holistic mind-body medicine into
reductionist treatments, turned abstract health properties of human beings into
statistical populations, and later added mathematical models into the research
models. Those presumptions have been accepted as the foundation of medicine,
without ever being questioned and validated. Our analysis using massive data
produced by tens of thousands of medical studies firmly refutes their validity.
Nearly all assumptions in medicine we have examined fail to hold, introduced
excessive inaccuracies, and are completely wrong. Failure is found at multiple
levels: the binary scale, the presumed statistical distribution, mathematical
models, synthetic drugs as medicines, the reductionist treatment approach,
ignorance of emotion and mind, etc. The flaws in mathematical models include
use of a linear number scale, summation of intensive properties, across-person
modeling, and failure to consider varying significance. Due to overwhelming
flaws, medicine lacks required accuracy for characterizing chronic diseases and
will never find predictable cures for chronic diseases. We must find that failure to find cures is
only a small part of problems, and a much bigger problem is that population-derived
treatments must endanger patients as long as the treatments are used on a
long-term basis and such treatments must have hurt human species for the entire
history. However, their adverse effects are hidden due to massive organ
functional capacities, a large number of interference factors and insufficient
follow-up time in studies. Clinical trials have one-way biases against weak and
slow-delivering factors. Each of the potentially thousands of harmful and toxic
substances might have been found to be harmless; but in reality they actually
work jointly to hurt humans, species and the planet.
B. Limitations in Clinical Trials
Flaws in clinical trials include (1)
misuse of statistical population as presumption without considering research
purposes and required accuracy; (2) failure to consider a massive number of
interfering factors and co-causal factors; (3) misusing mathematical models in
an attempt to change process attributes as if they were fungible and extensive;
(4) use of overly simplified mathematical models which cannot model complex
defense mechanisms; (5) misuse of the representative principle whereas
statistical mean cannot represent each person due to the body’s restrictions;
(6) failure to determine required accuracy relative to interfering factors; (7)
failure to address one-way biases caused by the symptom-based diagnosis method
and interfering factors; and (8) failure to note that population means cannot
be applied to any person including even those in the clinical trials. Each of
those problems can make study findings inaccurate, biased, and even
meaningless, and may create treatments that actually endanger patients.
A clinical trial cannot produce a right
result in following cases: (1) A
treatment is used only for a short time so that its treatment effect is hidden
among N interfering factors Fi (A brief exercise, brief diet and brief
emotional invention will show no detectable benefits); (2) a treatment does not
have the same or similar effects on all subjects (e.g., cancellation of
positive and negative effects); (3) all interfering factors have different
impacts on different subjects; (4)
clinical trials conceal side effects by cross-person averaging of side effects;
(5) drug side effects are realized slowly while the measured health properties
are interfered with by a large number of interfering factors. Clinical trials
or population study may be valid if (1) a strong treatment T is against N
interfering factors Fi, where T is much stronger than the total effect of all
interfering factors ?fi; (2) the accumulated effect of the treatment in a
sufficiently long period can stand out the accumulated interfering factors ?fi;
(3) the findings are not used for guiding treatment of chronic diseases and
accuracy is sufficient for the research purpose; or (4) all introduced errors
can be tolerated for practical reasons. The side effects are concealed due to
massive organ reserve capacities, interference effects, and their slow
materialization. Additional inaccuracies are introduced by use of the binary
scale, disease classification, and use of abstract definitions. The
representation principle is wrongly used in medical research, but can have even
more adverse impacts on the minority. Genetics are more similar between persons
within a race than between persons in different races. Computed average of
health property for a population of a majority race is expected to be different
from that for a population of a minority race. If a treatment is developed by a
clinical trial containing more persons of the majority race, the average will
be closer to the average of the majority race. This implies that the treatment
is more dangerous to the minority race than it is to the majority race. It is
well known that antibiotics doses developed in the U.S. may pose higher risks
to patients from Asian nations.
C. Unworkable Reductionist Treatments
Reductionist treatments cannot cure
chronic diseases because they (1) attempt to make impermissible trades in
health properties between different persons; (2) are not mismatched to specific persons’
biological networks; (3) fails to address the interlocking role of the CNS; (4)
lack any conceivable theoretical and practical basis to restore departures
of biological pathway attributes in the
metabolic pathways networks; (5) cannot work with multiple layers of defense
mechanisms; and (6) must distort the intervened pathway and other pathways in
the pathway network and thus cause drug side effects. They are the reasons that
medicine fails to find cures for chronic
diseases for centuries while most side effects are written off.
Population-derived treatments should be presumed to be dangerous if they are
used in long terms because they can slowly distort the person’s pathway
network. The process attributes values of any biochemical and metabolic pathway
is constrained by upper-stream, coupled and downstream pathways in the pathways
network. We predict that medicine will not find cures for chronic diseases but
may extend lives for real terminal diseases.
D. Wrongly Dismissed Benefits of Lifestyle
Factors
The magnitude of effects of lifestyle factors on chronic diseases and cancers is much larger than that of synthetic drugs. The beneficial effects of exercise can reduce death by almost 40%, and the impacts of emotional distress are very large as reflected in studies on wound healing, heart diseases, etc. However, clinical trials could not correctly detect their benefits due to (1) cancellation of positive effects and negative effects on different persons, (2) interfering effects of a large number of other factors, (3) the buffering effects of massive organ reserve capacities, and (4) slow delivery of beneficial effects of adjustments to lifestyle factors. Alterations in both organ functional capacities and body structures normally take long times, and disease reversal could take even longer times in some cases. It is agreed that preventive measures may be used to prevent diseases; but we believe that reversing fully developed diseases is not impossible except it requires much more efforts and time. Immediate cures for chronic diseases lie in use of plural weak factors to restore the abnormal process attributes in the personal metabolic pathways network. Use of evolution-compatible life style factors are presumed to be safe. Most biological properties (except genes and ages) can be altered by using lifestyles, foods, exercise, emotional management, and avoidance of toxic substances. The effect size of many influencing factors have been found in studies for different purposes; and effects of other weak factors have not been studied, but will be found to be important. Cancer self-resolution is not controlled by random odds but triggered by major changes in lifestyle even though patients may not be aware of what have happened. Studies involving weak environmental, dietary, emotional, lifestyle factors, etc. are generally wrong if findings are negative. However, if their findings were positive, the real treatment effects may be much stronger even though they are not necessarily good.
Figure 2: The black squares in (A) represent the normal values of processes attributes of metabolic pathways in the pathways network; the red arrows in (B) indicate how fault lifestyle factors cause attribute values to depart from their normal values; and the blue arrows in (C) indicate how the departed processes attributes are corrected by adjustments to lifestyle factors.
E. Mathematical Models for Personalized
Medicine
Real adverse effects of any weak factor
cannot be accurately characterized due to large vital organ reserve capacities,
slow delivery of its side effects, interference of a large number of other
factors, and inaccuracies introduced by the binary scale and disease
classification. Use of statistics must be viewed as junk science in most
applications (but they may be used to address true measurement errors; and also
same findings in studies can be used for non-medical purposes). The real life
model raises several challenges. The health degree and disease outcome of a
person depends on the totality of hundreds to thousands of factors. Any single
factor such as a nutrient’s status, a toxic substance, a foreign agent,
emotional distress, daily activity, even thinking habit, and any of their
combinations can control the health and disease outcome. The true effect of any
of the potential factors can be masked or distorted by any of thousands of
other factors or any of their combinations. We must presume that combined
effects of other interference factors are always much larger than the effect of
the treatment or the factor under investigation. This implies that treatment
benefits rated or estimated by the mean of the treatment group have absolutely
no relevance to any specific person. True cures must be based on personal
condition. However, we must face several challenges. First, we immediately see
practical difficulties to evaluate all potential factors (e.g., a person might
be under chronic poisoning of anything, nutritional imbalance, chronic foreign
agent, etc.). The second challenge is the interference of organ buffering
effects. Because the vital organs of most people have massive functional
capacities, symptom-based measurements nearly always produce false results
except when the investigated treatment is a super strong factor and follow-up
time is sufficiently long. Those difficulties imply that evaluation of a weak
treatment cannot be based on directly on existence of symptoms or lack of
symptoms. As we have shown, measured data do not tell reality. Another
challenge is practical inability to find and evaluate all potential
interference factors by invasive tests and medical diagnosis. Both the current research model and
treatment model cannot be used by doctors who practice personalized medicine. A new health model
must be based on combination methods with mathematical modeling as the central
tool. However, the mathematical model used in future is different from the
modeling approach used in the population medicine. It must have large modeling
capacities for any person and any health problem.
The real life model even refutes the
linear number scale, which is routinely used in pure mathematics. The
significance of a given unit change in temperature, blood pressure, vital
compound concentration, etc. always change, depending on whether the value is
close to a safe region or a death threshold. Moreover, choices of interventions and the level of
interventions must be based on the person’s vital signs and the totality of all
relevant influence factors. If a mathematician wants to prevent a death, he
cannot use the equation to make a prediction, but must take different measures
by looking at different values. Realistic mathematical models must reflect
varying scales and different significance of any health properties. Future
health mathematicians cannot assume that number additivity like 1+2=3 is valid.
Instead, the answer always depends on the body’s condition and other relevant
factors. The linear number scale may be used for approximation only if
introduced errors can be tolerated. Mathematicians must explore constraints
imposed by life phenomenon, life-maintaining processes, host structural
constraints, and overwhelming interactions, which can easily decide life or
death. We predict that human ability to develop realistic mathematical models
for the human body will be a limiting factor in future personalized medicine.
F. Terminal Impacts of Medicine On Human
Species
We regard the use of clinical trials and population-based research model as the main reasons for failure to find cures. By relying on flawed research findings, societies fail to explore cures that are immediately available but keep doing futile researches with no chance of success. The flawed medicine and flawed medical knowledge has found their way into all social strands, all federal/state policies, all federal/state laws, all social practices, existing media, etc. Wrong research findings become lame excuses for exposure to avoidable toxic substances such as food additives, synthetic flavors, food texture modifiers, avoidable pollutants, antibiotics, hormones, etc. Now, cancer, infertility, mental diseases, infectious diseases, etc. are striking mankind with unprecedented impacts. For example, the risk of getting cancer in a person’s lifetime rises from near nothing, to 0.04, to 0.4 and will soon reach a unit and even multiple units. The first cancer diagnosis ages are shifted to fifties, forties, thirties and even teens and newborns. Incidences like six cancer patients in a family and three cancer deaths in one family have become more and more common. There is no way to control the cancer pandemic, and no magic measure can ever arrest all disease momenta. Other health problems like infertility will become a civilization crisis. The failure of medicine is responsible for tens of million of annual premature deaths from chronic diseases in the world, the waste of a portion of $41 billion federal research funds administered by NIH, the use of more than a hundred billion dollars private research fund in the U.S., the trillion of medical spending in the U.S., and the wrong knowledge of published medical studies. Failure of medicine is responsible for the incurable notion that works like death spells on all humans. Our findings imply that the total stress of all toxic substances on human life and other species is responsible for the rapidly degraded ecosystem, environment and climate. Unfortunately, the U.S. medical establishment has built sophisticated protective devices to discriminate against, preclude, and suppress such findings. Refusal to correct the magnitudes of errors is equivalent to keeping death spells for patients and human species, killing other species, and destroying civilization.
None. The authors declare
that the research was conducted in the absence of any commercial or financial
relationships that could be construed as a potential conflict of interest.
The author(s) declared
that no grant was used in support of this research project.
Additional information is
provided in a supplemental document and additional factual information will be
stored in igoosa.com online database.